Kelly Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-74
| Closed | -$34.7K | – | 750 |
|
|
2024
Q2 | $34.7K | Hold |
74
| – | – | 0.01% | 267 |
|
|
2024
Q1 | $30.9K | Hold |
74
| – | – | 0.01% | 273 |
|
|
2023
Q4 | $30.1K | Hold |
74
| – | – | 0.01% | 262 |
|
|
2023
Q3 | $25.7K | Hold |
74
| – | – | 0.01% | 254 |
|
|
2023
Q2 | $26K | Hold |
74
| – | – | 0.01% | 261 |
|
|
2023
Q1 | $23.3K | Hold |
74
| – | – | 0.01% | 263 |
|
|
2022
Q4 | $21.4K | Hold |
74
| – | – | 0.01% | 261 |
|
|
2022
Q3 | $21.4K | Buy |
74
+2
| +3% | +$579 | 0.01% | 252 |
|
|
2022
Q2 | $20.3K | Hold |
72
| – | – | 0.01% | 253 |
|
|
2022
Q1 | $18.8K | Hold |
72
| – | – | 0.01% | 276 |
|
|
2021
Q4 | $15.8K | Hold |
72
| – | – | 0.01% | 292 |
|
|
2021
Q3 | $13.1K | Sell |
72
-14,445
| -100% | -$2.62M | 0.01% | 298 |
|
|
2021
Q2 | $72K | Buy |
14,517
+14,445
| +20,063% | +$71.6K | ﹤0.01% | 420 |
|
|
2021
Q1 | $15.5K | Hold |
72
| – | – | 0.01% | 249 |
|
|
2020
Q4 | $17K | Hold |
72
| – | – | 0.01% | 213 |
|
|
2020
Q3 | $19.6K | Hold |
72
| – | – | 0.01% | 175 |
|
|
2020
Q2 | $20.9K | Hold |
72
| – | – | 0.02% | 155 |
|
|
2020
Q1 | $17.1K | Hold |
72
| – | – | 0.02% | 151 |
|
|
2019
Q4 | $15.8K | Hold |
72
| – | – | 0.01% | 189 |
|
|
2019
Q3 | $12.2K | Buy |
72
+6
| +9% | +$1.02K | 0.01% | 204 |
|
|
2019
Q2 | $12.1K | Hold |
66
| – | – | 0.01% | 200 |
|
|
2019
Q1 | $12.1K | Buy |
+66
| New | +$12.1K | 0.01% | 201 |
|